@FiercePharma: FDA to rewarn docs on Plavix, Prilosec combo. Article | Follow @FiercePharma
> Roche got the FDA nod to market its drug Herceptin as a first-line treatment for patients with advanced stomach cancer. Roche release | Report
> Actelion has announced an 800 million Swiss franc ($829 million) share buyback and reiterated its desire to stay independent, knocking hopes the Swiss biotech group could be sold and sending its shares lower. Report
> E.U. antitrust regulators plan to review drug patent settlements struck this year to delay cheaper generics, as part of their crackdown on illegal deals, a senior European Commission official said. Report
> Genzyme says its leukemia drug Clolar failed to meet its key treatment goal in a late-stage study of the drug as a potential treatment for acute myeloid leukemia. Report
> Two more patients taking Biogen Idec's multiple sclerosis drug Tysabri have developed a potentially deadly brain infection known as PML, the company says. Report
> Sihuan Pharmaceutical, China's largest cardio-cerebral vascular drugmaker, raised $741 million after its IPO sold at the top of its indicated range, a source with direct knowledge of the deal said. Report
> Japan's Nichi-Iko Pharmaceutical plans to acquire 33.4 percent of South Korea's Aprogen through a private placement. Report
Biotech News
@FierceBiotech: Amylin shares crater after FDA rejects Bydureon app. News | Follow @FierceBiotech
@JohnCFierce: I used to think the FDA was just getting a bit tougher. Now I wonder if it's becoming excessively cautious. Anyone have thoughts on that? Follow @JohnCFierce
> Cardiome shares plunge after FDA red lights vernakalant Ph3. Report
> In fresh setback, Lilly scuttles Ph3 teplizumab program. Article
> Novartis biosimilars point to a blockbuster future. Item
> Zealand Pharma tests chilly IPO waters. News
Vaccines News
> A flu vaccine made using dog kidney cells appears to be as safe and effective as one produced using chicken eggs--the traditional, albeit slower method, according to a study. Report
> Charity bankrolls brain cancer vaccine trial. News
> MannKind starts Phase II melanoma vax trial. Article
> Duke researchers to test mosaic HIV vax candidate. Item
> Australia accused of wasting millions on swine flu vax. Story
Manufacturing News
> J&J: Another recall, another earnings rise. Report
> Union leads worker blockade of Sanofi plant. Story
> "Inadequates" in Gilead response led to FDA warning. Article
> Newly posted warnings cite repeat violations. News
> Nigeria is test-bed for online vs. offline fakes detection. Story
> Pfizer buys seat at biosimilars table next to Biocon. Article
And Finally... The first European company to produce a drug from a genetically modified animal will soon begin distributing its treatment to patients. Report